Trial Profile
Dose-ranging study of cetrorelix in men with benign prostatic hyperplasia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Cetrorelix (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Therapeutic Use
- Sponsors AEterna Zentaris Inc
- 05 Nov 2010 New trial record.